جست‌وجوی استاد و پژوهشگر

Elizabeth Zhengمشاهده پروفایل

دانشیار

• Transplant Hepatology
• Liver Cancer
• Hepatitis B
• +۵ مورد دیگر

Elizabeth Zheng, MD, is an Associate Professor of Medicine at the University of California, San Francisco (UCSF) School of Medicine, where she specializes in transplant hepatology. She provides clinical care through the UCSF Liver Transplant Program and conducts research focused on improving access to liver care and liver-cancer screening for underserved populations. She co-founded the Asian Liver Health Center and is board-certified in transplant hepatology, gastroenterology, and internal medicine. Education & Training MD – New York Medical College, 2011 Internal Medicine Residency – Montefiore Medical Center (Albert Einstein College of Medicine affiliate), 2014 Gastroenterology Fellowship – Einstein Medical Center, Philadelphia, 2017 Transplant Hepatology Fellowship – UCSF, 2018 Research Interests Dr. Zheng’s scholarly work centers on two major themes: Expanding access to high-quality liver care among underserved and minority populations, particularly Asian Americans. Developing and validating practical strategies for liver-cancer surveillance, including ultrasound-based recall algorithms and real-world management of hepatocellular carcinoma. She has additional expertise in drug-induced liver injury related to herbal and dietary supplements, having authored multiple reviews and prospective analyses on this topic. Publication Trends Across more than a dozen peer-reviewed articles since 2010, Dr. Zheng has advanced knowledge in hepatocellular carcinoma surveillance, COVID-19-associated liver injury, and supplement-related hepatotoxicity. Her collaborative multicenter studies have informed evidence-based guidelines and public-health recommendations. Clinical & Outreach Roles Co-founder, Asian Liver Health Center Attending Transplant Hepatologist, UCSF Liver Transplant Program Multisite clinical practice locations in San Francisco (400 Parnassus Ave and satellite clinics)

• Gastrointestinal Pathology
• Inflammatory Bowel Disease
• Colorectal Carcinoma
• +۷ مورد دیگر

Lindsay Alpert is an Associate Professor in the Department of Pathology at the University of Chicago's Pritzker School of Medicine. As a surgical pathologist specializing in gastrointestinal pathology, Dr. Alpert provides expert diagnostic services for neoplastic and non-neoplastic diseases of the gastrointestinal tract, biliary tree, and pancreas. Dr. Alpert received her MD from Columbia University College of Physicians and Surgeons in 2012. She completed her residency in Anatomic Pathology and fellowship in Gastrointestinal and Hepatic Pathology at the University of Chicago, finishing her fellowship in 2016 and residency in 2017. Dr. Alpert's research focuses on gastrointestinal pathology with particular expertise in inflammatory bowel disease, colorectal carcinoma, and the gut microbiome. Her work examines dysplasia patterns in IBD patients, histologic features of enteropathies, and the impact of therapeutic interventions on gastrointestinal tissues. She has made significant contributions to understanding the histologic spectrum of various gastrointestinal conditions and their clinical implications, with numerous publications in high-impact journals like Modern Pathology and Gastroenterology. Analysis of Dr. Alpert's recent publications reveals a strong focus on gastrointestinal pathology, particularly inflammatory bowel disease and colorectal neoplasia. Her work spans diagnostic pathology, molecular characterization of gastrointestinal tumors, and the impact of therapeutic interventions. Many studies examine dysplasia patterns in IBD patients across different age groups and presentations, while others investigate rare gastrointestinal conditions and their histologic features. Her research often bridges basic science with clinical applications, examining how dietary and pharmacological factors influence gastrointestinal pathology. Dr. Alpert actively collaborates with numerous researchers and clinicians at the University of Chicago and beyond, contributing to multidisciplinary studies that bridge pathology with clinical gastroenterology and oncology. Her network includes prominent colleagues such as John Hart, Namrata Setia, and Shu-Yuan Xiao. Dr. Alpert maintains an active research laboratory focused on gastrointestinal pathology, where she mentors trainees and collaborates with colleagues on various research projects examining the histopathology of gastrointestinal diseases. Her team works closely with clinicians to translate pathological findings into improved diagnostic criteria and patient care, particularly for complex cases involving inflammatory bowel disease and gastrointestinal neoplasia.

Mark Morrisonمشاهده پروفایل

استاد مدعو

• Biomedical and Clinical Sciences
• Clinical microbiology
• Gastroenterology and hepatology
• +۳ مورد دیگر

Professor Mark Morrison is an Affiliate Professor at the School of Chemistry and Molecular Biosciences, University of Queensland, and holds roles as Chair & Group Leader of Metagenomics at the Frazer Institute within the Faculty of Health, Medicine and Behavioural Sciences. His research focuses on clinical microbiology, gastroenterology, and the microbiome’s role in diseases like inflammatory bowel disease (IBD) and diabetes. He has extensive academic qualifications, including a Bachelor of Science from the University of New South Wales, a Master’s from James Cook University, and a PhD from the University of Illinois. Education : Bachelor of Science, University of New South Wales Masters (Research) of Science, James Cook University Doctor of Philosophy, University of Illinois His research interests span microbiome-driven health and disease mechanisms, particularly in gut-brain interactions, mucosal microbiota dynamics, and translational therapies. Over 390 works include studies on dietary FODMAP effects, microbiome-based IBD diagnostics, and SCFA therapy for diabetes. He leads interdisciplinary grants on microbiome manipulation and has advised numerous PhD students on topics like Crohn’s disease, archaeal biodiversity, and immune modulation. His recent articles highlight microbiota roles in SIBO, anastomotic leaks, and probiotic efficacy. While no explicit awards are cited, his contributions to gut microbiome science are recognized through active research collaborations and funding. He actively supervises students and chairs teams advancing metagenomics and clinical applications.

Annette Byrneمشاهده پروفایل

استاد

• Precision Medicine
• Molecular Imaging
• Angiogenesis
• +۷ مورد دیگر

Professor Annette Byrne is a leading academic at RCSI University of Medicine and Health Sciences , where she serves as Professor of Physiology and Head of the Precision Cancer Medicine (PCM) Group. She has held this position since 2019 after progressing through roles as Lecturer (2008), Senior Lecturer (2013), and Associate Professor (2017). Her research focuses on precision medicine approaches for colorectal and brain cancers , integrating multi-modality molecular imaging , Next Generation Sequencing , and patient-derived xenograft models . PhD in Cell Biology (University of York, 1999) John Kerner Fellowship in Gynaecologic Oncology (UCSF, 1999-2001) Scientist at Pharmacyclics Inc. (2001-2003) Senior Scientist at Angion Biomedica Corp. (2003-2005) Principal Investigator at UCD Conway Institute (2005-2008) Her research interest lies in precision cancer medicine , particularly elucidating predictive biomarkers (genomic, transcriptomic, proteomic) and identifying novel therapeutic targets . Key methodologies include radiomics , fluorescence-guided surgery , and systems modeling of apoptosis pathways. She has pioneered Ireland's first Tumour Xenograft Facility and Translational In Vivo Imaging Centre . Recent publications highlight her work on cross-species radiomics , cell-free DNA analysis , and glioblastoma microenvironment subtyping . Her Marie Curie networks (Gliotrain, Glioresolve) and COLOSSUS project have trained 25+ PhD researchers in brain cancer therapeutics. Over €45M in national/international grants Member of Royal Irish Academy (2025) Highly cited in Cancer Discovery , Annals of Oncology , and Nature journals She supervises multiple PhD candidates and leads the RCSI Precision Cancer Medicine Group , which utilizes computational approaches and molecular imaging to improve cancer treatment outcomes. Her GLIORESOLVE and EDIReX projects focus on tumor microenvironment manipulation and distributed PDX infrastructure.

Stuart Robertsمشاهده پروفایل

عضو هیئت علمی

• Hepatology
• Chronic Viral Hepatitis
• Primary Liver Cancer
• +۹ مورد دیگر

Stuart Roberts is an Adjunct Clinical Professor in the Department of Gastroenterology at Monash University, Faculty of Medicine, Nursing and Health Sciences. He is actively engaged in clinical research focusing on liver diseases, with a strong emphasis on chronic viral hepatitis, primary liver cancer, non-alcoholic fatty liver disease (NAFLD/MASLD), and non-invasive liver diagnostics such as Fibroscan. University: Monash University School: Faculty of Medicine, Nursing and Health Sciences Department: Department of Gastroenterology Academic Rank: Adjunct Clinical Professor His research interests center on advancing therapeutic strategies for chronic liver diseases through clinical trials and translational studies. Key areas include evaluating novel antiviral and immunomodulatory agents for hepatitis B and C, assessing new treatments for hepatocellular carcinoma, and investigating metabolic and dietary influences on liver health in aging populations. He also studies the role of liver stiffness measurement in disease screening and prognosis. The recent publications and active research projects (2024–2025) reflect a strong trend toward understanding the intersection of liver disease with aging, cardiovascular health, and neurocognitive outcomes. His work increasingly focuses on metabolic dysfunction-associated steatotic liver disease (MASLD), its systemic complications, and lifestyle or pharmacological interventions. Multiple phase 1 to phase 3 clinical trials are underway, particularly in NASH/MASH, hepatitis B immunotherapy, and cholangiocarcinoma. Scientific Awards: No awards mentioned in the provided text. Advising and Grants: Dr. Roberts serves as Primary Chief Investigator on 42 research projects, including major industry-sponsored clinical trials in hepatology. His leadership in multicenter studies highlights his role in shaping evidence-based liver disease management. While no formal student advising is mentioned, his collaborations involve trainees and junior researchers. Funding appears to come from pharmaceutical sponsors and institutional sources, supporting trials in antiviral, metabolic, and oncologic liver therapies. Labs and Research Teams: Dr. Roberts leads a clinical research team focused on hepatology within Monash Health. His work is highly collaborative, involving dietitians, oncologists, geriatricians, and neurologists. The research network includes national and international partners, with a strong presence in Australian multicenter liver disease studies.

Jon Heiselmanمشاهده پروفایل

استاد پژوهشی

• Biomedical Engineering
• Image-Guided Surgery
• Surgical Navigation
• +۳ مورد دیگر

Jon Heiselman is a Research Assistant Professor in the Department of Biomedical Engineering at Vanderbilt University School of Engineering. He serves as Associate Director of the Master of Engineering in Surgery and Intervention Program and leads research in image-guided surgical technologies. His work focuses on soft tissue deformation modeling, augmented reality applications, and computational frameworks for precision surgery. Education: PhD in Biomedical Engineering (Vanderbilt University, 2020) Advisor: Michael Miga, Harvie Branscomb Professor Research interests span image-guided surgical navigation, deformable registration algorithms, and digital twin modeling for therapeutic forecasting. Articles highlight advancements in soft tissue deformation correction, augmented reality integration, and machine learning approaches for real-time surgical guidance. Current affiliations include Vanderbilt's Biomedical Modeling Laboratory (BML) and the VISE Steering Committee. He contributes to NIH-funded training programs and has received recognition for his work in surgical data science and computational oncology.

• Pancreatic Cancer
• Gastrointestinal Cancer
• Surgical Oncology
• +۵ مورد دیگر

Dr. Andrew M. Lowy is a Professor of Surgery at the University of California San Diego School of Medicine, specializing in surgical oncology with a primary focus on pancreatic, liver, and gastrointestinal cancers. As a leading expert in pancreatic cancer treatment, he has pioneered the use of heated intraperitoneal chemotherapy (HIPEC) or 'chemo bath' for advanced abdominal cancers. Dr. Lowy serves on editorial boards of the Journal of Clinical Oncology and Annals of Surgical Oncology, and co-chairs the National Cancer Institute's Pancreatic Cancer Task Force. His research centers on pancreatic carcinogenesis and therapy, with particular emphasis on the RON receptor tyrosine kinase and its role as a potential therapeutic target. His laboratory develops models for testing novel therapeutics, focusing on translational applications for pancreatic cancer treatment. His work spans molecular biology, cancer signaling pathways, and innovative therapeutic approaches including targeted therapies and immunotherapies. Analysis of Dr. Lowy's recent publications reveals a strong emphasis on molecular mechanisms driving pancreatic cancer progression, with particular focus on tumor microenvironment interactions, metastasis mechanisms, and therapeutic resistance. His work increasingly incorporates advanced genomic and transcriptomic approaches while maintaining strong clinical relevance through participation in major cooperative group trials like SWOG. Dr. Lowy has secured significant research funding as Principal Investigator on multiple NIH grants, including several R01 awards from the National Cancer Institute, demonstrating the importance and impact of his research program. His extensive involvement in clinical trials reflects his commitment to translating laboratory findings into improved patient care. His laboratory and clinical team focus on advancing pancreatic cancer treatment through innovative surgical approaches, novel therapeutic targets, and biomarker development to guide personalized treatment strategies. The integration of basic science with clinical practice characterizes his comprehensive approach to improving outcomes for patients with gastrointestinal malignancies.

Bradley J. Ericksonمشاهده پروفایل

استاد

• Quantitative Imaging
• Computer-Aided Diagnosis
• Deep Learning
• +۳ مورد دیگر

Bradley J. Erickson, M.D., Ph.D. Bradley J. Erickson is a Professor of Radiology and Consultant at the Mayo Clinic in Rochester, Minnesota. He holds a joint appointment in the Division of Biomedical Statistics and Informatics. His research focuses on quantitative imaging, computer-aided diagnosis, and deep learning applications in medical imaging. He has pioneered systems for team science integration across imaging, genomics, and clinical data. Education MD/PhD in Biophysics/Biomedical Engineering, Mayo Graduate School Residency in Diagnostic Radiology, Mayo Clinic Research Interests Erickson's work emphasizes extracting diagnostic and prognostic information from medical images using machine learning and AI. Key areas include: Polycystic Kidney Disease (PKD) progression analysis via imaging Development of explainable AI models for cancer diagnosis (e.g., hepatocellular carcinoma) Privacy-preserving LLMs for echocardiography reports Awards & Recognition Team Science Award, Mayo Clinic (2020) Samuel J. Dwyer III, Ph.D., FSIIM Memorial Lectureship (2013) Chair, American Board of Imaging Informatics (2013–2018) Grants & Projects Principal Investigator for NIH-funded projects on synthetic medical images in AI fairness (2024–2025) Mayo Translational PKD Center (2010–2020) Objective decision support for clinical trials (2012–2015) Labs & Affiliations He leads the Imaging and Analysis Core within the Mayo Clinic Pirnie Translational PKD Center. Collaborates with teams in computational biology, radiology informatics, and clinical trials.

• Surgical Oncology
• Liver Transplantation
• Pancreatic Surgery
• +۵ مورد دیگر

Khe T. C. Tran is a surgical researcher at Erasmus University Medical Center in Rotterdam, Netherlands, specializing in hepatobiliary and pancreatic surgery with a strong focus on robotic and minimally invasive techniques. As a Researcher in the Department of Surgery, Tran actively contributes to advancing surgical methodologies and outcomes through rigorous clinical research. Dr. Tran's research interests span multiple critical areas in modern surgical practice, with particular expertise in robotic pancreaticoduodenectomy, liver resection techniques, and innovative transplantation approaches. The research portfolio demonstrates deep engagement with learning curve analysis in complex surgical procedures, quality assessment in surgical anastomoses, and expanding donor organ pools through domino transplantation strategies for metabolic disorders. Analysis of recent publications reveals a clear trend toward large-scale, multicenter collaborative studies examining the comparative effectiveness of robotic versus traditional laparoscopic approaches in hepatobiliary surgery. The research emphasizes practical clinical outcomes, risk factor identification, and systematic evaluation of surgical learning curves to improve patient safety and procedural success rates. Dr. Tran actively participates in major surgical research initiatives including the Dutch Pancreatic Cancer Group and Dutch Hepato Biliary Audit (DHBA), contributing to national surgical quality improvement efforts. The research output demonstrates significant collaboration with leading surgical centers both within the Netherlands and internationally, reflecting integration into broader surgical research networks. Current work focuses on refining robotic surgical techniques, particularly in pancreaticoduodenectomy and liver resection procedures, with emphasis on identifying critical learning curve milestones and developing objective assessment tools for surgical performance. The research program addresses important gaps in understanding the optimal implementation pathways for advanced surgical technologies in complex hepatopancreatobiliary procedures.

• Medical Imaging
• Biomedical Engineering
• Computer-Assisted Surgery
• +۳ مورد دیگر

Tamas Ungi is a Research Associate and Adjunct Assistant Professor at Queen's University, focusing on medical imaging, computer-assisted surgery, and biomedical engineering. His work bridges artificial intelligence applications with clinical needs in oncology, urology, and surgical education. Queen's University His research interests center on: 3D ultrasound imaging Surgical navigation systems Machine learning for medical diagnostics Tumor margin assessment Surgical skill evaluation Image-guided interventions Recent publications highlight advancements in radiation-free pediatric scoliosis assessment, AI-driven surgical evaluation metrics, and real-time ultrasound segmentation for breast-conserving surgery. He also explores electromagnetic tracking systems and NURBS-based surgical planning tools.

Guru Trikudanathanمشاهده پروفایل

استاد

• Gastroenterology
• Hepatology
• Advanced Endoscopy
• +۳ مورد دیگر

Guru Trikudanathan is a Professor in the Division of Gastroenterology, Hepatology and Nutrition, and serves as Section Lead for Advanced Endoscopy within the Department of Medicine at the University of Minnesota. His clinical and research focus centers on pancreatic diseases, advanced endoscopic techniques, and islet autotransplantation. Research Interests: Chronic pancreatitis, endoscopic interventions, islet transplantation, and metabolic complications of pancreatic surgery. Clinical Expertise: Management of complex pancreaticobiliary disorders, intraductal interventions, and nutritional support. His recent publications emphasize clinical outcomes in acute and chronic pancreatic diseases, novel endoscopic techniques, and metabolic assessments post-pancreatectomy. Studies include multicenter collaborations, guideline development, and evaluations of therapeutic approaches like pancrelipase administration and endoscopic ultrasound-guided procedures. He contributes to advancing endoscopic standards through research on guidewires, stents, and risk stratification tools for complications such as diabetes and visceral fat abnormalities. His work spans technical innovations, clinical decision-making, and patient-centered outcomes.

• Gastroenterology
• Clinical Education
• Quality Improvement
• +۵ مورد دیگر

Roles and Affiliations: Darrick K. Li is an Assistant Clinical Professor in the Department of Medicine (Digestive Diseases) at Yale School of Medicine, specializing in inpatient gastroenterology. He is a practicing gastroenterologist focused on acute gastrointestinal conditions such as bleeding, inflammatory bowel disease, and nutritional disorders, while also contributing to clinical education and quality improvement initiatives. Education: Dr. Li holds an MD and PhD from Columbia University (2014), with a BS and MS in Molecular Biophysics and Biochemistry from Yale University (2007). He completed internal medicine residency and gastroenterology fellowship at Massachusetts General Hospital. Research Interests: His work centers on gastrointestinal bleeding management, endoscopic techniques, anticoagulation strategies, and quality improvement in hospitalized patients. He also investigates rare gastrointestinal diseases and clinical trial methodologies. Publications: Dr. Li’s research spans 20 years, with recent emphasis on anticoagulation deprescription in GI bleeding, endoscopic cancer management, and liver disease pathophysiology. His articles reflect interdisciplinary approaches to clinical challenges, leveraging systematic reviews and collaborative studies. Awards: Notable recognitions include the AASLD Emerging Liver Scholar Award (2016), Yale Quality & Safety Grant (2021), and excellence in clinical teaching (2018). He is an active member of the American College of Gastroenterology and American Gastroenterological Association. Teaching and Grants: He mentors medical students, residents, and fellows, emphasizing hands-on clinical training. His grants support innovations in GI hospitalist care and evidence-based practices. Recent news highlights his team’s development of AI models for GI bleeding detection, reflecting cutting-edge translational research.

Jonathan M. Hernandezمشاهده پروفایل

استاد بالینی

• Liver Metastases
• Cancer Biology
• Cell Biology
• +۱۲ مورد دیگر

Dr. Jonathan M. Hernandez is a Clinical Professor of Surgery at George Washington University and an Associate Professor of Surgery at Uniformed Services University of the Health Sciences. He serves as an Investigator in the Surgical Oncology Program at the National Cancer Institute (NCI)/Center for Cancer Research (CCR) at NIH, where he leads the Liver Metastasis Biology Section and Surgical Oncology Section. His work bridges clinical practice and translational research in hepatic metastases and complex abdominal cancers. Education: M.D. (University of Florida, with honors) Residency: General Surgery (University of South Florida) Fellowships: Surgical Oncology and Hepatopancreatobiliary Surgery (Memorial Sloan Kettering Cancer Center) Dr. Hernandez’s research focuses on liver metastases from colorectal and neuroendocrine cancers, primary biliary tract malignancies, and adrenocortical carcinomas. His lab employs ex-vivo human tumor systems and exosome studies to identify therapeutic vulnerabilities, with emphasis on locoregional drug delivery and miRNA mechanisms. Current projects include pre-metastatic niche formation and spatial tissue phenotyping via IBEX imaging. His selected publications highlight 2020 studies on extracellular vesicle biomarkers and IBEX imaging, alongside 2015 landmark works on exosome-driven metastasis. These works span cancer biology, cell biology, and clinical oncology. Scientific Awards: Distinguished Clinical Teacher (2023) Dr. Hernandez mentors surgical residents and has authored over 175 peer-reviewed publications. His lab at NIH, established in 2016, has hosted 20 surgical residents. He leads clinical trials in cholangiocarcinoma, metastatic colorectal cancer, and adrenocortical carcinoma, including Phase 2 trials for gemcitabine/oxaliplatin chemotherapy and PDS01ADC combinations.

• Surgical Oncology
• Gastrointestinal Surgery
• Pancreatic Cancer
• +۳ مورد دیگر

Professor Jochen Gaedcke is an active surgical oncology specialist at University Medical Center Göttingen's Faculty of Medicine, Department of Surgery. His supervisory role spans 15 doctoral theses from 2017-2025, demonstrating his sustained academic leadership in gastrointestinal and cancer research. Position: Professor of Surgery Supervision Period: 2017-2025 (ongoing) Thesis Topics: Primarily focused on gastrointestinal malignancies and surgical outcomes Professor Gaedcke's research centers on surgical oncology with particular emphasis on pancreatic and colorectal cancers. His work investigates tumor microenvironment characteristics (particularly fibrosis in pancreatic cancer), molecular mechanisms of treatment response (KRAS mutations, p53 pathways), and clinical outcomes following gastrointestinal procedures. His supervision portfolio reveals a consistent focus on improving diagnostic methods, treatment efficacy, and complication management in visceral surgery. Analysis of his supervised publications shows a strong trend toward translational research bridging basic science discoveries with clinical applications. Approximately 60% of the theses focus on gastrointestinal cancers (pancreatic, colorectal, gastric), 25% on surgical complications and outcomes, and 15% on diagnostic innovations. The work demonstrates increasing sophistication in molecular analysis techniques over time, with recent theses incorporating advanced biomarker discovery and personalized treatment approaches. Professor Gaedcke has supervised 15 doctoral candidates to completion between 2017-2025, indicating a robust mentoring program. His students have investigated diverse aspects of surgical oncology, with several focusing on pancreatic cancer (3 theses), colorectal cancer (4 theses), and diagnostic methods (3 theses). This mentoring activity demonstrates his central role in training the next generation of surgical researchers in Germany. His laboratory work appears to focus on tumor microenvironment analysis, particularly the role of fibrosis in pancreatic cancer progression and treatment response. The collaborative nature of his work is evident from co-authorship on multiple publications with colleagues across pathology, molecular biology, and clinical departments.

Bryan Burtمشاهده پروفایل

استاد

• Thoracic Surgery
• Surgical Oncology
• Robotic Surgery
• +۵ مورد دیگر

Dr. Bryan Burt serves as Professor and Chief of the Division of Thoracic Surgery at Baylor College of Medicine, where he also directs the General Thoracic Surgery Fellowship program and oversees faculty mentorship within the Michael E. DeBakey Department of Surgery. A Harvard-trained thoracic surgeon and surgical oncologist, he specializes in robotic and minimally invasive approaches for complex thoracic malignancies and benign conditions, emphasizing multidisciplinary patient-centered care. His educational foundation includes a BA from New York University, MD from Weill Medical College of Cornell University, and dual residencies in General Surgery and Thoracic Surgery at Brigham & Women’s Hospital/Harvard Medical School. Dr. Burt's research program centers on improving surgical outcomes for thoracic cancers through translational science, with particular focus on malignant pleural mesothelioma, lung cancer, and thymic tumors. His NIH-funded laboratory investigates onco-immunological mechanisms to develop novel biomarkers and therapeutic strategies, bridging bench discoveries to clinical applications in robotic surgery and multimodal cancer treatment. Analysis of his 14 recent publications reveals a dominant research trajectory in malignant pleural mesothelioma, spanning genomic subtyping, immunoproteogenomic profiling, and surgical predictability modeling. This work integrates molecular oncology with surgical innovation, demonstrating consistent emphasis on identifying prognostic biomarkers and optimizing resection techniques for thoracic malignancies. His scientific accolades include the Norton Rose Fulbright Faculty Excellence Award for Enduring Education and Early Career Faculty Award for Excellence in Patient Care at Baylor College of Medicine, Alpha Omega Alpha honor society induction, and multiple departmental prizes from Weill Cornell and Brigham & Women’s Hospital including the Peter Bent Brigham Scholar Award and Clarence Coryell Prize in Surgery. As Program Director for the Thoracic Surgery Fellowship, Dr. Burt mentors surgical trainees in advanced robotic techniques while leading the Systems Onco-Immunology Laboratory. His NIH-funded research portfolio includes a dedicated mesothelioma grant, supporting investigations into tumor microenvironment interactions and immunotherapeutic applications. Clinical grants focus on optimizing minimally invasive approaches for high-risk thoracic patients. The Systems Onco-Immunology Laboratory, directed by Dr. Burt, conducts translational research on immune-tumor interactions in mesothelioma and lung cancer. The team employs immunoproteogenomic techniques to identify therapeutic targets, with current projects examining interleukin-4 receptor signaling and myeloid cell dynamics in pleural malignancies.